ENZO BIOCHEM INC Quarterly Common Stock, Shares, Issued from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Enzo Biochem Inc quarterly Common Stock, Shares, Issued history and growth rate from Q2 2011 to Q1 2024.
  • Enzo Biochem Inc Common Stock, Shares, Issued for the quarter ending April 30, 2024 was 51.2M shares, a 3.14% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 51.2M +1.56M +3.14% Apr 30, 2024 10-Q 2024-06-13
Q4 2023 50.5M +1.76M +3.61% Jan 31, 2024 10-Q 2024-03-13
Q3 2023 50.5M +1.77M +3.63% Oct 31, 2023 10-Q 2023-12-15
Q2 2023 50M +1.28M +2.62% Jul 31, 2023 10-Q 2024-06-13
Q1 2023 49.7M +949K +1.95% Apr 30, 2023 10-Q 2023-06-14
Q4 2022 48.7M +261K +0.54% Jan 31, 2023 10-Q 2023-03-20
Q3 2022 48.7M +249K +0.51% Oct 31, 2022 10-Q 2022-12-12
Q2 2022 48.7M +249K +0.51% Jul 31, 2022 10-K 2023-11-03
Q1 2022 48.7M +249K +0.51% Apr 30, 2022 10-Q 2022-06-09
Q4 2021 48.5M +244K +0.51% Jan 31, 2022 10-Q 2022-03-14
Q3 2021 48.5M +577K +1.2% Oct 31, 2021 10-Q 2021-12-15
Q2 2021 48.5M +577K +1.2% Jul 31, 2021 10-K 2022-10-14
Q1 2021 48.5M +581K +1.21% Apr 30, 2021 10-Q 2021-06-11
Q4 2020 48.2M +670K +1.41% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 47.9M +338K +0.71% Oct 31, 2020 10-Q 2020-12-11
Q2 2020 47.9M +338K +0.71% Jul 31, 2020 10-K 2021-10-12
Q1 2020 47.9M +334K +0.7% Apr 30, 2020 10-Q 2020-06-09
Q4 2019 47.6M +316K +0.67% Jan 31, 2020 10-Q 2020-03-06
Q3 2019 47.6M +364K +0.77% Oct 31, 2019 10-Q 2019-12-10
Q2 2019 47.6M +375K +0.79% Jul 31, 2019 10-K 2020-10-19
Q1 2019 47.6M +395K +0.84% Apr 30, 2019 10-Q 2019-06-10
Q4 2018 47.2M +163K +0.35% Jan 31, 2019 10-Q 2019-03-11
Q3 2018 47.2M +198K +0.42% Oct 31, 2018 10-Q 2018-12-10
Q2 2018 47.2M +676K +1.45% Jul 31, 2018 10-K 2019-10-15
Q1 2018 47.2M +755K +1.63% Apr 30, 2018 10-Q 2018-06-11
Q4 2017 47.1M +786K +1.7% Jan 31, 2018 10-Q 2018-03-12
Q3 2017 47M +714K +1.54% Oct 31, 2017 10-Q 2017-12-07
Q2 2017 46.5M +239K +0.52% Jul 31, 2017 10-K 2018-10-15
Q1 2017 46.4M +152K +0.33% Apr 30, 2017 10-Q 2017-06-08
Q4 2016 46.3M +200K +0.43% Jan 31, 2017 10-Q 2017-03-13
Q3 2016 46.3M +211K +0.46% Oct 31, 2016 10-Q 2016-12-08
Q2 2016 46.3M +206K +0.45% Jul 31, 2016 10-K 2017-09-27
Q1 2016 46.3M +197K +0.43% Apr 30, 2016 10-Q 2016-06-08
Q4 2015 46.1M +718K +1.58% Jan 31, 2016 10-Q 2016-03-09
Q3 2015 46.1M +1.32M +2.94% Oct 31, 2015 10-Q 2015-12-08
Q2 2015 46.1M +1.82M +4.12% Jul 31, 2015 10-K 2016-10-13
Q1 2015 46.1M +2.24M +5.11% Apr 30, 2015 10-Q 2015-06-09
Q4 2014 45.4M +3.06M +7.23% Jan 31, 2015 10-Q 2015-03-12
Q3 2014 44.8M +3.47M +8.41% Oct 31, 2014 10-Q 2014-12-09
Q2 2014 44.2M +3.67M +9.05% Jul 31, 2014 10-K 2015-10-13
Q1 2014 43.8M +4.14M +10.4% Apr 30, 2014 10-Q 2014-06-09
Q4 2013 42.3M +2.72M +6.88% Jan 31, 2014 10-Q 2014-03-11
Q3 2013 41.3M +1.78M +4.52% Oct 31, 2013 10-Q 2013-12-10
Q2 2013 40.6M +1.07M +2.72% Jul 31, 2013 10-K 2014-10-09
Q1 2013 39.7M +535K +1.37% Apr 30, 2013 10-Q 2013-06-10
Q4 2012 39.6M +517K +1.32% Jan 31, 2013 10-Q 2013-03-12
Q3 2012 39.5M +447K +1.15% Oct 31, 2012 10-Q 2012-12-10
Q2 2012 39.5M +450K +1.15% Jul 31, 2012 10-K 2013-10-15
Q1 2012 39.1M Apr 30, 2012 10-Q 2012-06-11
Q4 2011 39.1M Jan 31, 2012 10-Q 2012-03-12
Q3 2011 39M Oct 31, 2011 10-Q 2011-12-12
Q2 2011 39M Jul 31, 2011 10-K 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.